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iversity of Coronaviruses in Bats: Insights Into Origin of
ARS Coronavirus
.K.P. Lau ∗, P.C.Y. Woo, K.S.M. Li, Y. Huang, C.S.F. Lam,
.W.S. Poon, H.W. Tsoi, K.H. Chan, K.Y. Yuen
The University of Hong Kong, Hong Kong, China
Background: Although the ﬁnding of SARS coronavirus
SARS-CoV) in caged palm civets suggested that wild animals
re the origin of SARS-CoV, subsequent studies suggested
hat civet may have served only as an ampliﬁcation host.
n 2005, we identiﬁed a coronavirus closely related to SARS-
oV (bat-SARS-CoV) in Chinese horseshoe bats. However, it
emains to be determined if bat-SARS-CoV or other coron-
viruses in bats are the direct progenitor of SARS-CoV.
Methods: To understand the diversity and evolution of
oronaviruses in bats, a 2-year surveillance study for coro-
aviruses was conducted in bats from various rural areas
n Hong Kong. As coronaviruses are known to have high
ecombination frequency, the genomes of the identiﬁed
ovel coronaviruses were also sequenced and analyzed to
etermine possible recombination events responsible for
nterspecies transmission.
Results: Among 1389 bats of 16 species from 24 different
ocations, coronaviruses were identiﬁed from anal swabs of
32 (9.5%) bats by RT-PCR. Phylogenetic analysis revealed
t least seven novel coronaviruses from seven different bat
pecies, in addition to bat-SARS-CoV. Five of them belonged
o group 1 coronaviruses while two belonged to group 2 coro-
aviruses. Besides bat-SARS-CoV, Chinese horseshoe bats
ere found to harbor another novel group 1 coronavirus.
he genome of this virus represents the smallest coronavirus
enome and possessed a unique spike protein evolutionar-
ly distinct from the rest of the genome and containing a
5-amino acid peptide homologous to a corresponding pep-
ide within the RBM of spike protein of SARS-CoV, suggesting
common evolutionary origin in the spike protein of this
roup 1 bat coronavirus, bat-SARS-CoV, and SARS-CoV.
Conclusion: Bats are important reservoir for a huge diver-
ity of coronaviruses, including SARS-CoV-like viruses. The
nding of another group 1 coronavirus in Chinese horse-
hoe bats with a homologous peptide to SARS-CoV warrants
urther investigations on the origin of the SARS-CoV spike
rotein.
oi:10.1016/j.ijid.2008.05.019
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nalysis of Putative Virulence Factors in Enterococcus
aecium Isolated from Different Sources in Iran
. Jahangiri 1,∗, M. Talebi1, G. Eslami2, M.R. Pourshaﬁe1
Pasteur Institute of Iran, Tehran, Iran (Islamic Republic of)
Shaheed Beheshti Medical University, Tehran, Iran (Islamic
epublic of)Background: Enterococci have emerged as a leading
ause of nosocomial infections. The potential virulence
actors include a cytolytic toxin, gelatinase, an aggrega-
ion substance, the enterococcal surface protein (Esp) and
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yaluronidase. Our knowledge about the contribution of
hese virulence factors to the pathogenesis of enterococcal
nfections is still limited.
Methods: A total of 98 strains containing, 49 clinical
ancomycin-resistant Enterococcus faecium (cl-VREFm) and
9 environmental VREFm (en-VREFm), were included in this
tudy. The phenotypical characterization was performed by
heir abilities to adhere to Vero cell line and to associate
heir phenotypes with the presence of known virulence
enes detected within their genomes by PCR. The following
enes were ampliﬁed by PCR: asa1 (aggregation substance),
yl A, B, M (cytolysin), hyl (hyaluronidase), gelE (gelatinase)
nd esp (enterococcal surface protein). The transferability
f esp gene were examined by ﬁlter mating tests. The strains
ere typed by Pulsed-ﬁeld gel electrophoresis.
Results: The genes that encode cytolysin and aggregation
ubstance was never detected in isolates, whereas gelE and
sp genes was detected in both clinical and environmental
trains and hyl gene was only detected in clinical isolates
28%).The following data were obtained in this study: 81% of
l-VREFm and 80% of en-VREFm isolates were positive for esp
ene, the gelE gene was detected in all of clinical and 47% of
nvironmental isolates. Strong adhesion was observed only
n clinical strains. None of the esp genes were transferable
y conjugation tests. According to PFGE results the isolates
ere heterogeneous.
Conclusion: Environmental isolates were equipped with
ewer virulence factors than clinical isolates and presence
f virulence factors in environmental isolates demonstrates
hat they can be potentially virulent for human. There was
correlation between PCR and phenotypic tests in clinical
trains. Phenotypic testing revealed the existence of appar-
ntly silent gelE and esp genes among environmental strains.
oi:10.1016/j.ijid.2008.05.020
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mmunogenicity of Novel Consensus-Based DNA Vaccines
gainst Chikungunya Virus
. Muthumani1,∗, K. Lankaraman1, D. Laddy1, S.
undaram2, C. Chung1, E. Sako1, P. Vijayachari 3, A.
han4, N. Sardesai 1, J. Kim4, D. Weiner1
University of Pennsylvania School of Medicine, Philadel-
hia, PA, USA
Dr.MGR Educational and Research Institute, Chennai, India
Regional Medical Research Centre (ICMR), Port Blair, India
VGX Pharmaceuticals Inc, Philadelphia, PA, USA
CHIKV is an emerging arbovirus and is an important human
athogen that causes a syndrome characterized by fever,
eadache, rash, nausea, vomiting, myalgia, arthralgia and
ccasionally neurological manifestations such as acute limb
eakness. It is also associated with a fatal haemorrhagic
ondition. CHIKV is geographically distributed from Africa
hrough Southeast Asia and South America, and its transmis-
ion to humans is mainly through Aedes species mosquitoes.
he frequency of recent epidemics in the Indian Ocean
slands suggests that something else was carrying the virus,
s Aedes aegypti are not found there. In fact, the relative
sian tiger mosquito, Aedes albopictus, was present and has
aised concern in the world health community regarding the
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potential for a CHIK virus pandemic. Efforts to monitor the
disease will only provide minimal warning in a global soci-
ety, and steps must be taken to prevent the morbidity and
mortality associated with a possible pandemic. There is no
speciﬁc treatment for Chikungunya virus and there is no
vaccine currently available. We propose a novel consensus-
based approach to vaccine development, employing a DNA
vaccine strategy that can provide more highly cross-reactive
cellular immunity against CHIK virus. The vaccine cassette
was designed based on Capsid (Cap) and Envelope (E1)
speciﬁc consensus sequences with several modiﬁcations,
including codon optimization, RNA optimization, the addi-
tion of a Kozak sequence, and a substituted immunoglobulin
E leader sequence. The expression of Cap and envelope
E1 was evaluated using T7-coupled transcription/translation
and immuno blot analysis. A recently developed, adap-
tive constant-current electroporation technique was used to
immunize mice (both Balb/C & C57BL/6 mice strain) with an
intramuscular injection of plasmid coding for the CHICK-Cap
and E1. We show such constructs can induce strong cellular
immunity against CHIK-Cap and E1 antigens. The analysis
of speciﬁc antibody responses suggested that CHIK-E1 could
induce a strong E1 speciﬁc antibody response. Epitope map-
ping results indicated that there is an increase in the breadth
and magnitude of cross-reactive cellular responses induced
by both the Capsid and Envelope immunogen. These prop-
erties suggest that such a consensus immunogen deserves
further examination for its potential to serve as a component
antigen in a CHIK vaccine cocktail.
doi:10.1016/j.ijid.2008.05.021
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Post-Exposure Vaccination with a Highly Attenuated Vac-
cinia Vaccine, LC16m8, for Protection of Nonhuman
Primates from Monkeypox
M. Saijo1,∗, Y. Ami1, Y. Suzaki1, N. Nagata1, H. Hasegawa1,
M. Ogata1, S. Fukushi1, T. Mizutani1, I. Iizuka1, I. Kurane2,
T. Kurata1, S. Morikawa1
1 National Institute of Infectious Diseases, Tokyo, Japan
2 National Institute of Infectious Diseases (Musashimu-
rayama), Musashimurayama, Japan
Introduction: A highly attenuated smallpox vaccine,
LC16m8, is generated from parent strain, vaccinia virus Lis-
ter, by passages of Lister in primary rabbit kidney cells at a
temperature of 30 ◦C. LC16m8 lacks expression of the full-
length B5R membrane protein, one of the most important
viral membrane proteins for induction of immune response
to vaccinia virus, due to a frameshift mutation in the gene.
A single vaccination with LC16m8 protects non-human pri-
mates (NHPs) from monkeypox, monkeypox virus infection.
In the present study, the efﬁcacy of LC16m8 as a thera-
peutic vaccine was evaluated in protection of NHPs from
monkeypox.
Materials and Methods: Twenty-two NHPs (Macaca fasci-
cularis) were used. The NHPs were immunized with LC16m8
or mock followed by subcutaneous inoculation of monkey-
pox Zr-599. Three were mock-immunized and infected with
the virus. Three were infected with the virus and then immu-
nized with LC16m8. Three, 3, and 5 NHPs were infected with
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he virus 3, 7, and 14—24 days after vaccination, respec-
ively. Clinical manifestations weremonitored. Viremia level
nd antibody response were determined by the quantita-
ive real-time PCR and IgG-ELISA, respectively. Pathological
xamination was carried out in these subjects.
Results: Post-exposure vaccination with LC16m8 for
HPs, which were infected with monkeypox virus, improved
he clinical manifestation of monkeypox, while all the naive
ubjects were nearly lethal. Vaccination with LC16m8 7 days
efore monkeypox virus challenge completely protected
HPs from monkeypox. Viremia level in the post-exposure
accinated subjects was signiﬁcantly lower than that in the
aive subjects.
Discussion: LC16m8 has been re-produced and stockpiled
n Japan for the possible threat of bioterrorism with variola
irus as a bioweapon. Based on these results, it is suggested
hat LC16m8 may protect humans from smallpox, if they
ere immunized with LC16m8 immediately after the event
f variola virus infection.
oi:10.1016/j.ijid.2008.05.022
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istribution and Genetic Diversity of Plasmodium fal-
iparum Erythrocyte Binding Antigen 175 and Clinical
utcome of Malaria in the Kassena-Nankana District
. Egyir ∗, C. Brown, M. Wilson, K. Koram
Noguchi Memorial Institute for Medical Research, Accra,
hana
The Erythrocyte Binding Antigen 175 (EBA 175) is a
75 kDalton Plasmodium falciparum antigen which plays a
ajor role in erythrocyte recognition by the parasite. It
lso induces antibodies which inhibit merozoite invasion.
BA 175 has been sequenced from FCR-3 and CAMP strains
f Plasmodium falciparum. The sequences were identical in
ost parts of the gene, differences were apparent in the
23bp segment in the FCR-3 strain, the F-genotype, and
he 342bp segment, the C-genotype. Parasite strains pos-
ess either one or the other segment and never both. The
unctions and potential effects of this dimorphism remain
nclear. This study therefore investigated the relationship
etween this dimorphism and clinical outcome of malaria.
nested polymerase chain reaction (PCR) was used to deter-
ine the genotypes of the parasite strains that exhibit this
imorphism in severe, mild and healthy controls of malaria
rom the Kassena Nankana District (KND), an area which
ad been earmarked for future vaccine trial. A total of 299
amples were analysed, 232 of these samples were positive
ith Plasmodium falciparum infections, these comprised 75
32.2%), 76 (32.6%) and 81 (35.5%) samples of severe, mild
nd healthy controls of malaria respectively, were geno-
yped for the EBA-175 gene. The severe samples, had a
istribution of 44 (58.66%), 24 (32%) and 7 (9.3%) of the
, C and CF EBA-175 genes respectively; the mild samples
omprised, 42 (55.3%), 29 (38%), and 5 (6.6%) of the F, C
nd CF EBA-175 genes respectively; the healthy controls:
9 (72%), 21 (26%), and 13 (16%) of the F, C and CF EBA-
75 genes respectively. A chi-square test revealed that the
ixed genotype (CF) is signiﬁcantly associated with severe
alaria (p = 0.04; OR = 8.23, 95% CI = 1.048—64.7), whereas
